AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer
Linglong Yin(Central South University), Xiong Li(Central South University)
Cited by 12
Related Papers
PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2018|126
Novel Interactions between FOXM1 and CDC25A Regulate the Cell Cycle
|PLoS ONE|2012|42
AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer
|Oncogenesis|2023|23
SKP2 inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability
|British Journal of Cancer|2024|10